A September 2024 article in the journal Biomedicines reviewing the findings of clinical trials for ivermectin and chloroquine ...

The first to launch was the ACTT-1 trial, though it didn't have that name when it began at the University of Nebraska Medical ...

A cohort study finds that hydroxychloroquine use in cutaneous lupus erythematosus reduces the risk of developing systemic ...

U.S. outpatient prescriptions for hydroxychloroquine and ivermectin ... and earmarking public funding for clinical trials of new drugs are good places to start,” said Dr. John Mafi, associate ...

and the recently announced results from the UK's Recovery trial both showed that hydroxychloroquine does not result in the reduction of mortality of hospitalised COVID-19 patients, when compared ...

The World Health Organization halted the hydroxychloroquine arm of its SOLIDARITY trial at the beginning of the month, in patients who are already hospitalised. This followed a pause a month after ...

An influential study that found hydroxychloroquine increased the risk of death in COVID-19 patients has been withdrawn a week after it led to major trials being halted, adding to the confusion ...

U.S. outpatient prescriptions for hydroxychloroquine and ivermectin ... and earmarking public funding for clinical trials of new drugs are good places to start." Dr. John Mafi, associate professor ...

Five years after Donald Trump declared a national COVID emergency, here's what the research says about face masks.

The UK’s RECOVERY trial is a case in point ... proving that dexamethasone was helpful, that hydroxychloroquine was not, and much more. In 2022 Landray set out to build on that success by ...

Between 500 and 1,000 people globally are now dying every week from COVID. This winter, healthcare in much of the developed ...